Skip to content
  • Tuesday, 27 October 2026
  • 11:15 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead Sciences and Vir Biotechnology Expand Strategic Oncology Partnership in Multi-Billion-Dollar T-Cell Engager Deal for Solid Tumors
Pharmaceutical R&D

Gilead Sciences and Vir Biotechnology Expand Strategic Oncology Partnership in Multi-Billion-Dollar T-Cell Engager Deal for Solid Tumors

Teuku Ryan Oct 16, 2026 0

Gilead Sciences and Vir Biotechnology have significantly expanded their strategic research and development alliance through a newly finalized licensing agreement…

Read More
Pharmaceutical R&D

Sanofi and Regeneron Expand Landmark Pharma Alliance in $8bn Deal to Co-Develop Next-Generation Long-Acting Antibodies

Teuku Ryan Oct 1, 2026 0

Building upon one of the most successful and enduring scientific partnerships in the history of the modern pharmaceutical industry, French…

Read More
Pharmaceutical R&D

WuXi XDC and Ona Therapeutics Expand Partnership Through Exclusive Global Licensing Agreement for Advanced Antibody-Drug Conjugate Platform

Teuku Ryan Sep 19, 2026 0

In a significant expansion of their ongoing strategic partnership, WuXi XDC Cayman has entered into an exclusive global licensing agreement…

Read More
Pharmaceutical R&D

Gilead Sciences and PAHO Partner to Expand Twice-Yearly Lenacapavir PrEP Access Across Latin America and the Caribbean

Teuku Ryan Sep 17, 2026 0

The landscape of global human immunodeficiency virus (HIV) prevention is undergoing a critical transformation following a landmark agreement between biopharmaceutical…

Read More
Pharmaceutical R&D

Encoded Therapeutics Secures $275M in Series F Financing to Advance Groundbreaking Gene Therapy for Dravet Syndrome and Expand Clinical Pipeline

Teuku Ryan Sep 10, 2026 0

Encoded Therapeutics has officially closed a massive $275 million Series F financing round, marking a critical financial milestone for the…

Read More
Pharmaceutical R&D

BeOne Medicines Invests $300 Million to Expand Hopewell, New Jersey Manufacturing and Research Operations, Pushing Total US Investment Past $1 Billion

Teuku Ryan Jul 24, 2026 0

BeOne Medicines is significantly bolstering its presence in the United States with a substantial $300 million investment earmarked for the…

Read More
Clinical Diagnostics & Pathology

Labcorp and CHOP Launch Pediatric Diagnostics Partnership to Expand Advanced Testing and Drive Clinical Lab Growth

Reynand Amr Wu May 24, 2026 0

This strategic collaboration, formally announced in early 2024, unites two powerhouses in healthcare: Labcorp, a global leader in clinical laboratory…

Read More
Clinical Diagnostics & Pathology

Labcorp and Children’s Hospital of Philadelphia Forge Alliance to Revolutionize Pediatric Diagnostics and Expand National Access

Reynand Amr Wu May 16, 2026 0

The landscape of clinical diagnostics is poised for a significant transformation following the announcement of a strategic collaboration between Labcorp,…

Read More
Pharmaceutical R&D

Eli Lilly Pledges $4.5 Billion to Expand Indiana Manufacturing, Bolstering US Pharmaceutical Supply Chain

Teuku Ryan May 8, 2026 0

Eli Lilly and Company is significantly expanding its manufacturing footprint in Indiana with a substantial $4.5 billion investment, pushing its…

Read More
Clinical Diagnostics & Pathology

Labcorp and CHOP Launch Pediatric Diagnostics Partnership to Expand Advanced Testing and Drive Clinical Lab Growth

Reynand Amr Wu May 2, 2026 0

The diagnostic landscape for pediatric patients is poised for significant transformation following the announcement of a strategic collaboration between Labcorp,…

Read More

Posts pagination

1 2
Universal Critical Accretion Rate Discovered in Black Hole Jet Formation Unifies Stellar and Supermassive DynamicsHumanity’s African Origins: A Sweeping Genetic Analysis Unveils a Complex Network, Not a Single SourceTWiV 1291: A Foot in the Door for CytomegalovirusTWiV 1289: Building a better hepatitis B trap
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ